These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20712485)

  • 21. Discriminating between serological responses to European-genotype live vaccine and European-genotype field strains of porcine reproductive and respiratory syndrome virus (PRRSV) by peptide ELISA.
    Oleksiewicz MB; Stadejek T; Maćkiewicz Z; Porowski M; Pejsak Z
    J Virol Methods; 2005 Nov; 129(2):134-44. PubMed ID: 15992937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Porcine Reproductive and Respiratory Syndrome Virus isolates differ in their susceptibility to neutralization.
    Martínez-Lobo FJ; Díez-Fuertes F; Simarro I; Castro JM; Prieto C
    Vaccine; 2011 Sep; 29(40):6928-40. PubMed ID: 21807060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation of Porcine Reproductive and Respiratory Syndrome Virus GP5-Specific, Neutralizing Monoclonal Antibodies From Hyperimmune Sows.
    Young JE; Dvorak CMT; Graham SP; Murtaugh MP
    Front Immunol; 2021; 12():638493. PubMed ID: 33692807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociation of porcine reproductive and respiratory syndrome virus neutralization from antibodies specific to major envelope protein surface epitopes.
    Li J; Murtaugh MP
    Virology; 2012 Nov; 433(2):367-76. PubMed ID: 22981434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutralizing antibody formation in swine infected with seven strains of porcine reproductive and respiratory syndrome virus as measured by indirect ELISA with peptides containing the GP5 neutralization epitope.
    Plagemann PG
    Viral Immunol; 2006; 19(2):285-93. PubMed ID: 16817771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the use of non-pathogenic porcine circovirus type 1 as a vaccine delivery virus vector to express antigenic epitopes of porcine reproductive and respiratory syndrome virus.
    Piñeyro PE; Kenney SP; Giménez-Lirola LG; Opriessnig T; Tian D; Heffron CL; Meng XJ
    Virus Res; 2016 Feb; 213():100-108. PubMed ID: 26555162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The primary GP5 neutralization epitope of North American isolates of porcine reproductive and respiratory syndrome virus.
    Plagemann PG
    Vet Immunol Immunopathol; 2004 Dec; 102(3):263-75. PubMed ID: 15507310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Porcine B-cells recognize epitopes that are conserved between the structural proteins of American- and European-type porcine reproductive and respiratory syndrome virus.
    Oleksiewicz MB; Bøtner A; Normann P
    J Gen Virol; 2002 Jun; 83(Pt 6):1407-1418. PubMed ID: 12029156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GP5 of porcine reproductive and respiratory syndrome virus (PRRSV) as a target for homologous and broadly neutralizing antibodies.
    Popescu LN; Trible BR; Chen N; Rowland RRR
    Vet Microbiol; 2017 Sep; 209():90-96. PubMed ID: 28528961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and γδ T Cell Responses and Confers Heterologous Protection.
    Cao QM; Ni YY; Cao D; Tian D; Yugo DM; Heffron CL; Overend C; Subramaniam S; Rogers AJ; Catanzaro N; LeRoith T; Roberts PC; Meng XJ
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of antigenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV) in a modified live-attenuated porcine circovirus type 2 (PCV2) vaccine virus (PCV1-2a) as a potential bivalent vaccine against both PCV2 and PRRSV.
    Piñeyro PE; Kenney SP; Giménez-Lirola LG; Heffron CL; Matzinger SR; Opriessnig T; Meng XJ
    Virus Res; 2015 Dec; 210():154-64. PubMed ID: 26239318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Independent evolution of porcine reproductive and respiratory syndrome virus 2 with genetic heterogeneity in antigenic regions of structural proteins in Korea.
    Kwon T; Yoo SJ; Sunwoo SY; Lee DU; Je SH; Park JW; Park CK; Lyoo YS
    Arch Virol; 2019 Jan; 164(1):213-224. PubMed ID: 30317394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis and antigenic characterization of a new East European subtype 3 porcine reproductive and respiratory syndrome virus isolate.
    Karniychuk UU; Geldhof M; Vanhee M; Van Doorsselaere J; Saveleva TA; Nauwynck HJ
    BMC Vet Res; 2010 Jun; 6():30. PubMed ID: 20525333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic analysis of a porcine reproductive and respiratory syndrome virus 1 strain in China with new patterns of amino acid deletions in nsp2, GP3 and GP4.
    Zhang Q; Song Z; Yu Y; Huang J; Jiang P; Shan H
    Microb Pathog; 2020 Dec; 149():104531. PubMed ID: 32980471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic diversity in envelope genes of contemporary U.S. porcine reproductive and respiratory syndrome virus strains influences viral antigenicity.
    Chen Z; Collin E; Peddireddi L; Clement T; Gauger P; Hause BM
    Res Vet Sci; 2017 Dec; 115():432-441. PubMed ID: 28759862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative contribution of porcine reproductive and respiratory syndrome virus open reading frames 2-4 to the induction of protective immunity.
    Kimpston-Burkgren K; Correas I; Osorio FA; Steffen D; Pattnaik AK; Fang Y; Vu HLX
    Vaccine; 2017 Aug; 35(34):4408-4413. PubMed ID: 28689650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of immune responses following homologous reinfection of pigs with European subtype 1 and 3 porcine reproductive and respiratory syndrome virus strains that differ in virulence.
    Weesendorp E; Stockhofe-Zurwieden N; Nauwynck HJ; Popma-De Graaf DJ; Rebel JM
    Vet Microbiol; 2016; 182():64-74. PubMed ID: 26711030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.
    Geldhof MF; Van Breedam W; De Jong E; Lopez Rodriguez A; Karniychuk UU; Vanhee M; Van Doorsselaere J; Maes D; Nauwynck HJ
    Vet Microbiol; 2013 Dec; 167(3-4):260-71. PubMed ID: 24041768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of porcine reproductive and respiratory syndrome virus deletion mutants: correlation with the porcine antibody response to a hypervariable site in the ORF 3 structural glycoprotein.
    Oleksiewicz MB; Bøtner A; Toft P; Grubbe T; Nielsen J; Kamstrup S; Storgaard T
    Virology; 2000 Feb; 267(2):135-40. PubMed ID: 10662609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an experimental inactivated PRRSV vaccine that induces virus-neutralizing antibodies.
    Vanhee M; Delputte PL; Delrue I; Geldhof MF; Nauwynck HJ
    Vet Res; 2009; 40(6):63. PubMed ID: 19674539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.